Skip to main content

Table 7 Logistic regression analysis of factors associated with muscle symptoms among Rosuvastatin users

From: Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

Independent Variables

P-Value

Adjusted Odds Ratio (OR)

95% CI

(Lower)

95% CI

(Upper)

Combination therapy

(Ezetimibe)

0.033

1.778

1.046

3.020

ABCG2 rs2231142

Carriers

0.280

1.379

0.770

2.469

Back to article page

Human Genomics

ISSN: 1479-7364